| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.093 | 0.09 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.1 |